User:Dimitrios iliopoulos

Dimitrios Iliopoulos is a world expert in the field of systems biology. He has developed a novel approach, called "network-based chemical screening", which resulted in the identification of multiple novel drugs against different human diseases.

Dimitrios Iliopoulos received his PhD from the Integrated Biomedical Graduate Program of Ohio State University in 2006. Then, he was a post-doctoral fellow in the Department of Biological Chemistry and Molecular Pharmacology at Harvard Medical School. In 2010, he became assistant professor in the Department of Microbiology and Immunobiology at Harvard Medical School and in the Department of Cancer Immunology at Dana-Farber Cancer Institute, where he is interested in identifying how intracellular inflammatory stimuli and perturbations in the tumor microenvironment contribute to the transformation of normal cells into cancer cells. Furthermore, his research is focused on the identification and molecular characterization of cancer cell subpopulations with tumor-initiating properties. Dimitrios Iliopoulos has published his research in top tier scientific journals, including Cell, Cancer Cell, Molecular Cell, PNAS and Cancer Research.